CN1256631A - 治疗哺乳动物真菌感染的方法和组合物 - Google Patents

治疗哺乳动物真菌感染的方法和组合物 Download PDF

Info

Publication number
CN1256631A
CN1256631A CN96197725A CN96197725A CN1256631A CN 1256631 A CN1256631 A CN 1256631A CN 96197725 A CN96197725 A CN 96197725A CN 96197725 A CN96197725 A CN 96197725A CN 1256631 A CN1256631 A CN 1256631A
Authority
CN
China
Prior art keywords
nikemycin
nikkomycin
administration
compositions
saline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN96197725A
Other languages
English (en)
Chinese (zh)
Inventor
R·F·赫托尔
A·沙鲍尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaman Pharmaceuticals Inc
Original Assignee
Shaman Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaman Pharmaceuticals Inc filed Critical Shaman Pharmaceuticals Inc
Publication of CN1256631A publication Critical patent/CN1256631A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN96197725A 1995-08-28 1996-08-28 治疗哺乳动物真菌感染的方法和组合物 Pending CN1256631A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US52028995A 1995-08-28 1995-08-28
US08/520,289 1995-08-28
US08/697,706 1996-08-27
US08/697,706 US5789387A (en) 1995-08-28 1996-08-27 Methods and compositions for treating fungal infections in mammals

Publications (1)

Publication Number Publication Date
CN1256631A true CN1256631A (zh) 2000-06-14

Family

ID=27060105

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96197725A Pending CN1256631A (zh) 1995-08-28 1996-08-28 治疗哺乳动物真菌感染的方法和组合物

Country Status (10)

Country Link
US (1) US5789387A (https=)
EP (1) EP0850063A1 (https=)
JP (1) JP2001516332A (https=)
KR (1) KR19990044174A (https=)
CN (1) CN1256631A (https=)
AU (1) AU6906096A (https=)
BR (1) BR9610134A (https=)
CA (1) CA2230856A1 (https=)
IL (1) IL123498A0 (https=)
WO (1) WO1997007802A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2102210C (en) * 1991-05-06 1998-08-04 Mark Benson Andon Combined calcium and vitamin d supplements
US8846740B2 (en) 2011-01-04 2014-09-30 Biological Responsibility, Llc Biotherapeutics for the treatment of infectious diseases
JP6502930B2 (ja) * 2013-06-21 2019-04-17 イミジン， インコーポレイテッド 血液解析

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2928137A1 (de) * 1979-07-12 1981-02-05 Bayer Ag Neue nikkomycine, ein verfahren zu ihrer herstellung sowie ihre verwendung als schaedlingsbekaempfungsmittel
DE3020722A1 (de) * 1980-05-31 1981-12-10 Bayer Ag, 5090 Leverkusen Verfahren zur anreicherung von nikkomycin-gemischen
US4851389A (en) * 1987-03-25 1989-07-25 Miles Laboratories, Inc. Use of nikkomycin compounds to treat infections of dimorphic, highly chitinous fungi
US5521153A (en) * 1987-10-02 1996-05-28 Ciba-Geigy Corporation Synergistic antifungal protein and compositions containing same
US5134126A (en) * 1987-11-09 1992-07-28 Bayer Ag Antimycotic compositions of nikkomycin compounds and azole antimycotics
US5006513A (en) * 1987-11-09 1991-04-09 Miles Inc. Antimycotic compositions of nikkomycin compounds and azole antimycotica
US5194427A (en) * 1987-11-09 1993-03-16 Bayer Ag Antimycotic compositions of nikkomycin compounds and azole antimycotics
US5096889A (en) * 1987-11-09 1992-03-17 Bayer Ag Antimycotic compositions of nikkomycin compounds and azole antimycotics
ATE72119T1 (de) * 1987-11-09 1992-02-15 Bayer Ag Antimycotische zusammensetzungen aus nikkomycin- verbindungen und antimycotischem azol.
US4914087A (en) * 1988-02-29 1990-04-03 Bayer Ag Nikkomycin derivatives, antimycotic compositions of nikkomycin derivatives and azole antimycotics
US5091375A (en) * 1988-02-29 1992-02-25 Bayer Ag Nikkomycin derivatives
US5019560A (en) * 1988-10-03 1991-05-28 Bayer Ag Method for treating fungal infections with nikkomycin derivatives
US5149795A (en) * 1988-10-03 1992-09-22 Bayer Ag Nikkomycin derivatives
WO1991018984A2 (en) * 1990-06-07 1991-12-12 Mogen International N.V. New antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi
US5326561A (en) * 1992-12-15 1994-07-05 Cornell Research Foundation, Inc. Antifungal synergistic combination of enzyme fungicide and non-enzymatic fungicide and use thereof
US5236900A (en) * 1991-08-20 1993-08-17 Schering Corporation Anti-fungal agents
US5238926A (en) * 1991-08-20 1993-08-24 Schering Corporation Anti-fungal agents
US5346898A (en) * 1992-06-18 1994-09-13 Schering Corporation Anti-fungal uracil compounds
US5229123A (en) * 1991-10-09 1993-07-20 Hoffmann-La Roche Inc. Antifungal agents
US5614377A (en) * 1994-02-28 1997-03-25 Myco Pharmaceuticals, Incorporated Methods for identifying inhibitors of fungal pathogenicity

Also Published As

Publication number Publication date
JP2001516332A (ja) 2001-09-25
AU6906096A (en) 1997-03-19
EP0850063A1 (en) 1998-07-01
CA2230856A1 (en) 1997-03-06
KR19990044174A (ko) 1999-06-25
MX9801538A (es) 1998-05-31
WO1997007802A1 (en) 1997-03-06
BR9610134A (pt) 1999-07-27
IL123498A0 (en) 1998-09-24
US5789387A (en) 1998-08-04
EP0850063A4 (https=) 1998-08-05

Similar Documents

Publication Publication Date Title
Malayeri et al. Antifungal agents: Polyene, azole, antimetabolite, other and future agents
EP1283708B1 (fr) Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
US20150190413A1 (en) Compositions and methods for the treatment of bladder cancer
SK5822002A3 (en) Method and compositions for administering taxanes orally to human patients
CN116942662B (zh) 麦角硫因(egt)预防和治疗脓毒症的用途
US20020193369A1 (en) Antifungal compounds and uses therefor
US20110105387A1 (en) Method of treatment with rapamycin
CN1256631A (zh) 治疗哺乳动物真菌感染的方法和组合物
Graybill et al. Treatment of experimental murine aspergillosis with BAY n7133
CN102525883B (zh) 一种伏立康唑栓剂及其制备方法和用途
US20110263659A1 (en) Analogs of 1-Methylnicotinamide
JP4221170B2 (ja) 非経口投与用の安定な組成物及びそれらの使用
CA2353613A1 (en) Preparations for intraurethral administration
WO2023249651A1 (en) Compositions and method for effective management of peritonitis
WO2010141068A1 (en) Opthalmic compositions of cyclosporin
EP4062907A1 (fr) Formulation par voie orale d'ivermectine et utilisations
JPWO2002098463A1 (ja) 抗真菌組成物
RU2804132C1 (ru) Применение фосфолипидной эмульсии, содержащей дигидрокверцетин, для защиты тканей донорского органа и профилактики его отторжения в трансплантологии
EP1206178A1 (en) A large animal model of invasive pulmonary aspergillosis in an immunocompromised host
US20220409651A1 (en) Anti-fungal compositions and methods for using same
Sionov et al. Treatment of murine systemic aspergillosis with polyene-intralipid admixtures.
CN118078793A (zh) Gw3965在制备减轻阿霉素心脏损伤的药物中的应用
US20210308174A1 (en) Treatment of irritable bowel syndrome with molybdenum
HK40123938A (zh) 用於治疗X-ALD的甲状腺β激动剂给药方案
Refai et al. Antifungals

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication